Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI
This study has been completed.
Study NCT00243152   Information provided by Pain and Analgesia Imaging and Neuroscience Group
First Received: October 19, 2005   Last Updated: February 3, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Facial Neuropathy
Additional conditions recognized in this trial
Facial Nerve Diseases
Facial Pain
Facies
More general conditions related to this trial
Cranial Nerve Diseases
Disease Attributes
Nervous System Diseases
Neurologic Manifestations
Pain
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
lamotrigine: 25mg and 50mg tablets
Additional drug interventions recognized in this trial
Lamotrigine
More general drug interventions related to this trial
Anticonvulsants
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Pain and Analgesia Imaging and Neuroscience Group
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services